M. Hubert et D. Lison, STUDY OF MUSCULAR EFFECTS OF SHORT-TERM PYRIDOSTIGMINE TREATMENT IN RESTING AND EXERCISING RATS, Human & experimental toxicology, 14(1), 1995, pp. 49-54
1. Pyridostigmine (PYR) pretreatment is used by the military to obtain
20-30% whole blood acetylcholinesterase (AChE) inhibition in order to
enhance the effectiveness of the standard therapeutic regimen for poi
soning by an organophosphate anticholinesterase agent. The present stu
dy was undertaken to investigate in a rat model the potential muscle d
amage produced by this pretreatment when given alone or combined with
physical exercise. 2. Grip strength and biochemical measurements, i.e.
serum creatine phosphokinase (CPK) activity and creatine urinary excr
etion rate, together with histological studies, were performed in rest
ing animals during a period of 14 days of PYR administration in a dose
producing 20-30% whole blood acetylcholinesterase inhibition. No evid
ence was found of a deleterious effect of this treatment on the skelet
al muscle. 3. In contrast, following physical exercise, the same treat
ment significantly exacerbated the biochemical changes reflecting a lo
ss of integrity in skeletal muscles, namely, increased CPK and urinary
creatine excretion rate. The significance of this observation remains
to be clarified.